- Home
- AIFF vs ECOR Comparison
AIFF vs ECOR Comparison
Compare AIFF & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIFF
- ECOR
- Stock Information
- Founded
- AIFF 2006
- ECOR 2005
- Country
- AIFF United States
- ECOR United States
- Employees
- AIFF N/A
- ECOR N/A
- Industry
- AIFF
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- AIFF
- ECOR Health Care
- Exchange
- AIFF NYSE
- ECOR Nasdaq
- Market Cap
- AIFF 37.9M
- ECOR 39.7M
- IPO Year
- AIFF N/A
- ECOR 2018
- Fundamental
- Price
- AIFF $3.03
- ECOR $7.52
- Analyst Decision
- AIFF
- ECOR Strong Buy
- Analyst Count
- AIFF 0
- ECOR 2
- Target Price
- AIFF N/A
- ECOR $25.50
- AVG Volume (30 Days)
- AIFF 2.8M
- ECOR 126.8K
- Earning Date
- AIFF 08-18-2025
- ECOR 08-06-2025
- Dividend Yield
- AIFF N/A
- ECOR N/A
- EPS Growth
- AIFF N/A
- ECOR N/A
- EPS
- AIFF N/A
- ECOR N/A
- Revenue
- AIFF $139,000.00
- ECOR $26,458,000.00
- Revenue This Year
- AIFF N/A
- ECOR $23.21
- Revenue Next Year
- AIFF N/A
- ECOR $44.10
- P/E Ratio
- AIFF N/A
- ECOR N/A
- Revenue Growth
- AIFF N/A
- ECOR 41.54
- 52 Week Low
- AIFF $1.86
- ECOR $4.47
- 52 Week High
- AIFF $17.20
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- AIFF 50.69
- ECOR 61.13
- Support Level
- AIFF $2.93
- ECOR $6.80
- Resistance Level
- AIFF $3.08
- ECOR $7.80
- Average True Range (ATR)
- AIFF 0.17
- ECOR 0.68
- MACD
- AIFF 0.01
- ECOR 0.11
- Stochastic Oscillator
- AIFF 57.14
- ECOR 62.11
About AIFF FIREFLY NEUROSCIENCE INC
Firefly Neuroscience Inc is an AI company developing neuroscientific solutions that improve outcomes for patients with mental illnesses and cognitive disorders. It is focused on the commercialization of its Brain Network Analytics (BNA) software platform (the "BNA Platform")and the discovery and clinical development of biomarkers that support outcomes for people suffering from mental illnesses and cognitive disorders. The Company has one reportable segment: the BNA platform. The Company derives revenue from North America.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.